ArticleDiscover mental health2026
Schizophrenia-related suicide mortality in the United States by sex, 1999-2023.
Article in Discover mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePeople with schizophrenia experience markedly elevated risk of suicide, yet national-level data on schizophrenia-related suicide mortality in the United States (US) remain limited. This serial cross-sectional, population-based study quantifies temporal trends in schizophrenia-related suicide deaths from 1999 through 2023 by sex.
methodsWe used final mortality data from the CDC WONDER Multiple Cause of Death database among US residents aged 15-74 years whose underlying cause of death was intentional self-harm or sequelae of intentional self-harm and whose death certificate listed schizophrenia, schizotypal disorder, or other delusional disorders as a contributing cause. Counts and mortality rates per 100,000 population were extracted and stratified by sex. Temporal trends were examined using joinpoint regression, with annual percent change (APC) estimated for each identified trend segment.
resultsFrom 1999 to 2023, there were 3507 schizophrenia-related suicide deaths, of which 76.7% were male and 23.3% were female. The overall mortality rate increased from 0.04 per 100,000 in 1999 to a peak of 0.09 per 100,000 in 2021, a 122% increase. Overall, joinpoint models showed a 2.4% annual increase from 1999 to 2016, followed by a 5.8% annual increase from 2016 to 2023. Among female decedents, rates rose from 1999 to 2012 (APC = 3.6%) and then stabilized. Among male decedents, rates increased gradually from 1999 to 2015 (APC = 2.4%) and accelerated thereafter (APC = 5.8%).
conclusionsSchizophrenia-related suicide mortality increased substantially in the US, particularly among male individuals in recent years. These findings underscore the need for enhanced suicide prevention and treatment efforts targeting individuals with schizophrenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.